Matt Kim is the Joint Head of US Biotech based in New York in the Global Healthcare Investment Banking Group at Jefferies where he leads the biotech practice advising corporate clients in corporate finance and merger and acquisition strategy. Prior to joining Jefferies, Mr. Kim was employed by UBS Investment Bank in 2003 in the Healthcare Investment Banking Group. Prior to joining UBS, Mr. Kim was a Howard Hughes Research Fellow at the Howard Hughes Medical Institute at Duke University where he focused his research on membrane-spanning proteins. Mr. Kim graduated from Duke University with a B.S. in Biology and Economics and was a University Scholar. Born and raised in the Annapolis, Maryland area, he now resides in New York City with his wife and two children.